Assess cardiac remodeling after Myocardial Infarction with Collagen Hybridizing Peptides (CHPs)

Myocardial Infarction (MI) initiates a complex remodeling process involving significant collagen damage. Accurately quantifying damaged collagen in cardiac tissue samples is essential for understanding patient outcomes and assessing treatment response.

Collagen Hybridizing Peptides (CHPs) offer the unique capability to selectively bind and quantify denatured collagen, enabling researchers to:

  • Visualize collagen damage as early as 3 days post-MI, enabling the tracking of early-stage remodeling and inflammatory responses
  • Correlate collagen damage directly with macrophage infiltration (CD68 staining), providing a detailed view of the inflammatory contribution to remodeling.
  • Provide quantifiable data, consistent with MMP activity studies, for use as a reliable secondary endpoint in clinical trials assessing post-MI recovery.

CHPs empower collagen targeting for diagnosis and treatment

Explore the power of targeted collagen analysis in MI research. Download our application flyer to learn how CHPs offer unique capabilities suited for advancing MI research.

See the Data

A versatile and sensitive solution for fibrosis characterization

CHPs enable the precise measurement of inflammation and tissue damage in a number of conditions.

Intensity of BCHP staining correlates with disease activity in MASH mouse model

At 3Helix, our CHP products provide:

  • Compatibility with most dyes, imaging probes, and automated staining platforms
  • Utility in histology, in vivo studies, and 3D cell cultures
  • Flexibility for use across any animal model and in human studies
  • The only product on the market to stain damaged collagen with applications available in total collagen staining

Our CHP products are conjugated with a variety of detection motifs for brightfield and fluorescence detection, and they can be customized to meet your unique needs. Visit our products page to learn more.

Explore our Products

Want to learn how CHPs can accelerate your Myocardial Infarction research or clinical trial?

Our experts are here to help.

Contact Us